Ralf Kuriyel
Chief Tech/Sci/R&D Officer at REPLIGEN CORPORATION
Net worth: 3 M $ as of 31/03/2024
Profile
Presently, Ralf Kuriyel is Senior Vice President-Research & Development at Repligen Corp. In the past he was Vice President-Research & Development for Pall Life Sciences and Vice President-Field Applications R&D at Pall Corp. Mr. Kuriyel received an undergraduate degree and a graduate degree from Rensselaer Polytechnic Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REPLIGEN CORPORATION
0.03% | 18/03/2024 | 17,719 ( 0.03% ) | 3 M $ | 31/03/2024 |
Ralf Kuriyel active positions
| Companies | Position | Start |
|---|---|---|
| REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18/10/2016 |
Former positions of Ralf Kuriyel
| Companies | Position | End |
|---|---|---|
| PALL CORPORATION | Corporate Officer/Principal | 01/10/2016 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Training of Ralf Kuriyel
| Tufts University | Doctorate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |
- Stock Market
- Insiders
- Ralf Kuriyel
